Understand the source comparison
SS-LUP-332 Research Cost vs Established Alternatives
Research-grade SS-LUP-332 from verified suppliers typically costs $180–$320 per 10mg vial at >98% purity, positioning it in the mid-range of novel metabolic research peptides. By comparison, MOTS-C Peptide, another mitochondrial-targeting compound with more ex
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research-grade SS-LUP-332 from verified suppliers typically costs $180–$320 per 10mg vial at >98% purity, positioning it in the mid-range of novel metabolic research peptides. By comparison, MOTS-C Peptide, another mitochondrial-targeting compound with more extensive preclinical literature, costs $140–$220 per 5mg, while 5-Amino-1MQ, an NNMT inhibitor with published human tolerability data, ranges from $160–$280 per gram in powder form. The cost calculus for whether SS-LUP-332 is worth it depends on three factors: your dosing protocol, study duration, and whether your research question requires a novel mechanism or could be answered with a more validated compound.
- For a standard 28-day murine study with 10mg/kg twice-daily dosing in 20 mice (average weight 25g), total SS-LUP-332 consumption would be approximately 140mg. Requiring 2–3 vials at $500–$900 total peptide cost. That's comparable to GW501516 (a PPARδ agonist with similar endurance-enhancing effects) but significantly more expensive than metformin or AICAR, both of which have decades of mechanistic literature and cost under $50 per study. The premium you're paying for SS-LUP-332 is mechanistic novelty: it's an ERR agonist in a research landscape dominated by AMPK and PPAR modulators. If your grant, publication strategy, or intellectual property development depends on that novelty, the compound is worth it. If you're conducting exploratory metabolic phenotyping and any exercise-mimetic would suffice, established alternatives offer better cost-per-data-point ratios.
- Real Peptides structures research peptide pricing to reflect synthesis complexity and purity verification costs, not market hype. Every batch of SLU PP 332 Peptide undergoes small-batch synthesis with exact amino-acid sequencing and third-party HPLC confirmation before release. That's why our pricing remains consistent regardless of trending research interest. When evaluating whether SS-LUP-332 is worth it from a budget perspective, calculate cost per experimental endpoint, not cost per milligram. A $300 peptide that produces three publishable datasets is a better investment than a $100 peptide that fails to replicate.